Search details
1.
A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN study.
BMC Cancer
; 23(1): 449, 2023 May 17.
Article
in English
| MEDLINE | ID: mdl-37198562
2.
PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients.
Gynecol Oncol
; 173: 98-105, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37105063
3.
To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study.
Cancer Causes Control
; 33(3): 403-415, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35079925
4.
Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients.
Ann Surg Oncol
; 29(5): 3322-3334, 2022 May.
Article
in English
| MEDLINE | ID: mdl-34994906
5.
Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice.
Qual Life Res
; 30(11): 3255-3266, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-33387291
6.
Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy.
Int J Cancer
; 143(11): 3008-3018, 2018 12 01.
Article
in English
| MEDLINE | ID: mdl-30183073
7.
Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells.
J Immunol
; 197(5): 1597-608, 2016 09 01.
Article
in English
| MEDLINE | ID: mdl-27481844
8.
Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian Cancer.
Int J Gynecol Cancer
; 26(2): 261-7, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26807562
9.
In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?
Oncologist
; 20(4): 344-50, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25795632
10.
Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasis.
Oncologist
; 18(6): 667-74, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23723333
11.
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
Nat Commun
; 14(1): 7018, 2023 11 02.
Article
in English
| MEDLINE | ID: mdl-37919269
12.
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab.
Front Cardiovasc Med
; 9: 1000846, 2022.
Article
in English
| MEDLINE | ID: mdl-36211552
13.
Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry.
Sci Rep
; 12(1): 3617, 2022 03 07.
Article
in English
| MEDLINE | ID: mdl-35256657
14.
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study.
Front Oncol
; 12: 957580, 2022.
Article
in English
| MEDLINE | ID: mdl-35928870
15.
COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.
J Infect
; 82(2): 282-327, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32853599
16.
Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients.
Eur J Cancer
; 150: 1-9, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33882374
17.
Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER).
Eur J Cancer
; 150: 232-239, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33934060
18.
How to manage patients with corticosteroids in oncology in the era of immunotherapy?
Eur J Cancer
; 141: 239-251, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33212339
19.
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Eur J Cancer
; 141: 62-81, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33129039
20.
ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer Phenotypes.
Cells
; 7(12)2018 Dec 06.
Article
in English
| MEDLINE | ID: mdl-30563263